AstraZeneca blamed the slowdown partly on a destocking dynamic in China following an inventory buildup in the first quarter.

While it remains unclear why AstraZeneca China President Leon Wang has been detained, news of his arrest comes just days ...

Leerink Partners analyst Andrew Berens has maintained their bullish stance on AZN stock, giving a Buy rating on November 6. Andrew ...

AstraZeneca advances its ambition to redefine cancer care ... evaluating Calquence compared with chlorambucil plus rituximab in first-line CLL in patients in China. Two oral presentations will share ...

European stocks drifted lower on Friday as China's top legislative body - the National People's Congress (NPC) - approved the State ...

AstraZeneca's China president has been detained by Chinese authorities amid investigation into illegal importation and ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Sarepta will discontinue its next generation of exon-skipping drugs for Duchenne muscular dystrophy over safety concerns, in ...

AstraZeneca's price plunge following a fraud investigation in China could be just the time to buy AZN stock as big picture ...

Pharmaceutical giant AstraZeneca said that the head of its China operations had been detained, after reports the firm was ...

Gatestone Institute senior fellow Gordon Chang discusses Trump's potential foreign policy regarding China and the hacking ...